Nanoliposomal CPT-11 (NL-CPT-11)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nanoliposomal CPT-11 (NL-CPT-11), covering 2015-01-07 to 2015-01-07. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas [Phase 1]